Quick Answer
QIAGEN N.V. reported Diluted EPS of $1.94 per share for fiscal year 2025.
QIAGEN N.V. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | $1.94 | +424.3% |
| 2024 | $0.37 | -75.0% |
| 2023 | $1.48 | -19.6% |
| 2022 | $1.84 | -16.7% |
| 2021 | $2.21 | +44.4% |
| 2020 | $1.53 | +950.0% |
| 2019 | -$0.18 | -122.0% |
| 2018 | $0.82 | +382.4% |
| 2017 | $0.17 | -50.0% |
| 2016 | $0.34 | -38.2% |
| 2015 | $0.55 | +14.6% |
| 2014 | $0.48 | +65.5% |
| 2013 | $0.29 | -46.3% |
| 2012 | $0.54 | +35.0% |
| 2011 | $0.40 | -33.3% |
| 2010 | $0.60 | -6.3% |
| 2009 | $0.64 | +45.5% |
| 2008 | $0.44 | — |
- QIAGEN N.V. showed an increase of +424.3% in Diluted EPS compared to the prior fiscal year.
- Over the 2008–2025 period, QIAGEN N.V.’s diluted eps has grown by 340.9% (from $0.44 per share to $1.94 per share).
- The most recent figure is from QIAGEN N.V.’s fiscal year 2025 report (Form 20-F), filed with the SEC on March 20, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: